Építés alatt – nem éles oldal
Belépés
Leállítva2. fázis

Massage for Prostate Cancer-Related Fatigue (mPROSTATE)

A legfontosabb adatok

Ki végzi
University of Utah
Hol
Salt Lake City (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Fázis
2. fázis
Résztvevők
28 fő vett részt
Kezdés
2022. jún. 17.
Befejezés
2025. aug. 2.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Swedish Massage Therapy (SMT)
  • Light Touch (LT) Control
  • Waitlist Control (WLC)
A regiszteradat frissítve
2026. július 13.
Miért állt le
Lack of Funding

Ki vehet részt

Életkor
45 év felett
Nem
Csak férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 20 feltétel megnézéseKevesebb

Ki vehet részt

  • Male subjects aged >= 45 years old
  • Histologically confirmed diagnosis of prostate cancer
  • Subjects must have completed radiation therapy >= 2 months, prior to registration
  • Subjects who have a score > 25 on the Brief Fatigue Inventory (BFI) at screening
  • Subjects who are fluent in speaking and reading English
  • Based on International Classification of Diseases (ICD)-10 proposed criteria, the patient must have a diagnosis of CRF with evidence from the history, physical exam, and laboratory findings that the fatigue is a consequence of cancer or cancer therapy and not primarily a consequence of any of the following:; Comorbid psychiatric disorders; Anemia (hemoglobin less than 10 g/dl); Hypothyroidism (thyroid stimulating hormone (TSH) greater than 4.6 micro-international units (uIU)/mL); Uncontrolled pain; Any medical or psychiatric condition or medication felt to be clinically contributing to fatigue based on the investigator's history, physical examination, and assessment. These medical circumstances may include:; The use of medications such as opioids, sedating anti-histamines, or neuroleptics; Medical problems associated with fatigue: chronic obstructive pulmonary disease, congestive heart failure, renal disease, hepatic dysfunction, uncontrolled autoimmune disease, neurological disorders such as multiple sclerosis or Parkinson's disease, and sleep apnea
  • Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines

Ki nem vehet részt

  • Current use of any medications or therapies listed as prohibited in Section 6.6.1
  • Treatment with corticosteroids or other immunosuppressants =< 6 months prior to registration, , unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement
  • Regular use of anti-inflammatory drugs including non-steroidal anti-inflammatory drugs and natural products thought to have anti-inflammatory properties, unless the medication is necessary to support patient wellbeing and unlikely to negatively impact study aims, per PI judgement
  • Change in prescribed dose of medications for anxiety or depression =< 4 weeks prior to registration
  • Change in fluoxetine dose within =< 8 weeks prior to registration
  • Other conditions or behaviors that, in the opinion of the treating investigator, may negatively impact study participation, including the following:; Illicit drug use; Shift work; Current dieting; Excessive regular use of alcohol (more than two 5-ounce glasses of wine or equivalents/day); Any instance of binge drinking (more than 7 drinks in a 24-hour period) =< 6 months prior to registration
  • Subjects meeting criteria for a current substance use diagnosis or current diagnoses of schizophrenia, depression, generalized anxiety disorder, bipolar disorder, dementia, delirium, or obsessive compulsive disorder (OCD)
  • Medical, psychiatric, cognitive, or other conditions that may compromise the subject's ability to understand the subject information, give informed consent, comply with the study protocol, or complete the study
  • Inability to lay prone comfortably for 25 minutes and inability to lay supine comfortably for 25 minutes, given the nature of the massage intervention
  • Body-mass index less than 18.5 (kg/m\^2)
  • Subjects who cannot comply with the protocol for any reason
  • Subjects who are actively suicidal or homicidal
  • Current and/or past use of massage for the treatment of fatigue

Helyszínek itt: Egyesült Államok

  • Huntsman Cancer Institute/University of UtahSalt Lake City, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This phase II trial investigates the effect of massage in decreasing prostate cancer-related fatigue. Massage therapy has well known health benefits. This trial aims to find out if massage and touch therapies reduce fatigue due to cancer, and to learn if these therapies are better than traditional medicine or psychology for cancer related fatigue.

A vizsgálat 3 csoportja

  • Swedish Massage Therapy (SMT)A vizsgált kezelés

    Patients receive SMT over 45 minutes once weekly for 6 weeks.

  • Light Touch (LT)Színlelt kezelés, összehasonlításként

    Patients receive LT over 45 minutes once weekly for 6 weeks.

    Kezelés: Light Touch (LT) Control

  • Waitlist Control (WLC)Már használt kezelés, összehasonlításként

    Patients will sit and relax for 45 minutes before completing study assessments at weeks 3 and 6.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. július 13.